Money control Boardroom 

http://www.moneycontrol.com/news/results-boardroom/why-did-infosys-cut-its-fy12-dollar-guidance-_649657.html

The company is chasing 12 large deals and with double digit growth in Europe and Life Sciences & Healthcare, the company is looking closely to one more from the sector in Europe with Big Pharma poised to enter a bullish growht worldwide...

Nope, no traction, CTS is mowing them down. Stay clued! 

Posted via email from The India Investment Post